OpenLegislation

The Misuse of Drugs (Amendment) (England, Wales and Scotland) Regulations 2015

S.I. 2015/231 · Made 12 February 2015

Original text. legislation.gov.uk does not revise statutory instruments, so later amendments are not shown here. Changes made to it are listed under each provision when known.

Dangerous Drugs, England And Wales

Dangerous Drugs, Scotland

Made 12th February 2015

Laid before Parliament 18th February 2015

Coming into force 11th March 2015

The Secretary of State makes the following Regulations in exercise of the powers conferred by sections 7, 10, 22 and 31 of the Misuse of Drugs Act 1971f1.

In accordance with section 31(3) of that Act the Secretary of State has consulted with the Advisory Council on the Misuse of Drugs.

Annotations to the whole text

Footnotes

f1

1971 c. 38; section 22 was amended by section 177(1) of, and paragraph 12 of Schedule 4, to the Customs and Excise Management Act 1979 (c. 2); there are amendments to section 31 but they are not relevant to these Regulations.

Contents

  1. 1Citation, commencement and extent
  2. 2Amendment of the Misuse of Drugs Regulations 2001
  3. 3Amendment of the Misuse of Drugs Regulations 2001
  4. Signature
  5. Explanatory note

1Citation, commencement and extent

(1)

These Regulations may be cited as the Misuse of Drugs (Amendment) (England, Wales and Scotland) Regulations 2015 and come into force on 11th March 2015.

(2)

These Regulations extend to England and Wales and Scotland.

2Amendment of the Misuse of Drugs Regulations 2001

The Misuse of Drugs Regulations 2001f1 are amended as follows.

3Amendment of the Misuse of Drugs Regulations 2001

In paragraph 1(a) of Schedule 1 (which specifies controlled drugs subject to the requirements of regulations 14, 15, 16 , 18, 19, 20, 23, 26 and 27)—

(a)

after “4-Bromo-2,5-dimethoxy-a-methylphenethylamine” insert—

“1-Cyclohexyl-4-(1,2-diphenylethyl)piperazine (MT-45)”;

(b)

after “4-Methyl-aminorex” insert—

“4-Methyl-5-(4-methylphenyl)-4,5-dihydrooxazol-2-amine (4,4’-DMAR)”.

Signature

Lynne Featherstone

Minister of State

Home Office

12th February 2015

Explanatory note

(This note is not part of the Regulations)

These Regulations amend the Misuse of Drugs Regulations 2001 (“the Regulations”). The schedule of the Regulations in which a controlled drug is placed primarily affects the extent to which the drug can be lawfully imported, exported, produced, supplied or possessed and dictates the record keeping, labelling and destruction requirements in relation to that drug. The controlled drugs placed in Schedule 1 to the Regulations are those subject to the tightest controls.

Regulation 3 adds a potent opoid known as MT-45 and a synthetic stimulant known as 4,4’-DMAR to Schedule 1 to the Regulations.

A full impact assessment of the effect that this instrument will have on the costs of business and the voluntary sector is available and is published with the Explanatory Memorandum alongside the instrument on www.legislation.gov.uk.